K. A. Ciazynska

Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease

Steven F. Baker, Kenneth G. C. Smith, J. Briggs, 2020 .

Engineered disulfide reveals structural dynamics of locked SARS-CoV-2 spike

J. Briggs, A. Carter, J. He, 2022, PLoS pathogens.

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope

J. Briggs, X. Xiong, Jincun Zhao, 2022, Nature Microbiology.

A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy

C. Lorenz, T. Bui, A. Drake, 2020, Communications Biology.

Brief Report Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease.

Steven F. Baker, Nikos, Myra, 2020 .